(S (NP (PRP We)) (VP (VBD aimed) (S (VP (TO to) (VP (VB enhance) (NP (NP (DT the) (NN performance)) (PP (IN of) (NP (DT a) (JJ supervised) (NN model)))) (PP (IN for) (NP (NP (NP (NP (JJ clinical)) (VP (VBN named))) (HYPH -) (NP (NN entity) (NN recognition) (PRN (-LRB- -LRB-) (NP (NN NER)) (-RRB- -RRB-)))) (VP (VBG using) (NP (JJ medical) (NNS terminologies))))))))) (. .))
(S (PP (IN In) (NP (NN order) (S (VP (TO to) (VP (VB evaluate) (NP (PRP$ our) (NN system)) (PP (IN in) (NP (NNP French)))))))) (, ,) (NP (PRP we)) (VP (VBD built) (NP (DT a) (NN corpus)) (PP (IN for) (NP (NP (CD 5) (NNS types)) (PP (IN of) (NP (JJ clinical) (NNS entities)))))) (. .))
(S (NP (PRP We)) (VP (VBD used) (NP (NP (NP (DT a) (ADJP (NN terminology) (HYPH -) (VBN based)) (NN system)) (PP (IN as) (NP (NN baseline)))) (, ,) (VP (VBN built) (PP (IN upon) (NP (NNP UMLS) (CC and) (NNP SNOMED)))))) (. .))
(S (ADVP (RB Then)) (, ,) (NP (PRP we)) (VP (VBD evaluated) (NP (NP (NP (DT a) (NN biGRU)) (HYPH -) (NP (NNP CRF))) (, ,) (CC and) (NP (NP (DT an) (NN hybrid) (NN system)) (VP (VBG using) (NP (NP (DT the) (NN prediction)) (PP (IN of) (NP (NP (DT the) (ADJP (NN terminology) (HYPH -) (VBN based)) (NN system)) (PP (IN as) (NP (NP (NN feature)) (PP (IN for) (NP (DT the) (NNP biGRU) (HYPH -) (NNP CRF)))))))))))) (. .))
(S (PP (IN In) (NP (NNP English))) (, ,) (NP (PRP we)) (VP (VBD evaluated) (NP (DT the) (NML (NML (NN NER) (NNS systems)) (PP (IN on) (NP (DT the) (NN i2b2) (HYPH -) (CD 2009)))) (NNP Medication) (NNP Challenge)) (PP (IN for) (NP (NP (NML (NNP Drug) (NN name)) (NN recognition)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD contained) (NP (CD 8,573) (NNS entities)) (PP (IN for) (NP (CD 268) (NNS documents))))))))) (. .))
(S (PP (IN In) (ADJP (JJ French))) (, ,) (NP (PRP we)) (VP (VBD built) (NP (NP (NNP APcNER)) (, ,) (NP (NP (DT a) (NN corpus)) (PP (IN of) (NP (NP (CD 147) (NNS documents)) (VP (VBN annotated) (PP (IN for) (NP (CD 5) (NNS entities)))))))) (PRN (-LRB- -LRB-) (NP (NN drug) (NN name)) (, ,) (NP (NN sign) (CC or) (NN symptom)) (, ,) (NP (NP (NN disease) (CC or) (NN disorder)) (, ,) (NP (JJ diagnostic) (NML (NN procedure) (CC or) (NN lab)) (NN test)) (CC and) (NP (JJ therapeutic) (NN procedure))) (-RRB- -RRB-))) (. .))
(S (NP (PRP We)) (VP (VBD evaluated) (NP (DT each) (NN NER) (NNS systems)) (S (VP (VBG using) (NP (NP (ADJP (JJ exact) (CC and) (JJ partial)) (NN match) (NN definition)) (PP (IN of) (NP (NP (NN F) (HYPH -) (NN measure)) (PP (IN for) (NP (NN NER))))))))) (. .))
(S (NP (DT The) (NNP APcNER)) (VP (VBZ contains) (NP (NP (CD 4,837) (NNS entities)) (SBAR (WHNP (WDT which)) (S (VP (VBD took) (NP (CD 28) (NNS hours)) (PP (IN to) (S (S (S (VP (VB annotate))) (, ,) (NP (DT the) (NN inter-annotator) (NN agreement)) (VP (VBD was) (ADJP (JJ acceptable) (PP (IN for) (NP (NN Drug) (NN name)))) (PP (IN in) (NP (JJ exact) (NN match))) (PRN (-LRB- -LRB-) (NP (CD 85) (NN %)) (-RRB- -RRB-)))) (CC and) (S (ADJP (JJ acceptable) (PP (IN for) (NP (NP (JJ other) (NN entity) (NNS types)) (PP (IN in) (NP (JJ non-exact) (NN match)))))) (PRN (-LRB- -LRB-) (NP (QP (SYM >) (CD 70)) (NN %)) (-RRB- -RRB-)))))))))) (. .))
(S (PP (IN For) (NP (NP (NN drug) (NN name) (NN recognition)) (PP (IN on) (NP (DT both) (NP (NN i2b2) (HYPH -) (CD 2009)) (CC and) (NP (NNP APcNER)))))) (, ,) (NP (NP (DT the) (NN biGRU)) (HYPH -) (NP (NNP CRF))) (VP (VBD performed) (ADVP (ADVP (RBR better)) (SBAR (IN that) (FRAG (NP (NP (DT the) (ADJP (NN terminology) (HYPH -) (VBN based)) (NN system)) (, ,) (PP (IN with) (NP (NP (DT an) (JJ exact) (HYPH -) (NN match)) (FRAG (NP (NP (NP (NN F) (HYPH -) (NN measure)) (PP (IN of) (NP (CD 91.1) (NN %)))) (CC versus) (NP (NP (QP (CD 73) (NN %) (CC and) (CD 81.9)) (NN %)) (CC versus) (NP (CD 75) (NN %)))) (ADVP (RB respectively)))))))))) (. .))
(S (ADVP (RB Moreover)) (, ,) (NP (DT the) (NN hybrid) (NN system)) (VP (VBD outperformed) (NP (DT the) (NNP biGRU) (HYPH -) (NNP CRF)) (, ,) (PP (IN with) (NP (NP (NP (DT an) (JJ exact) (HYPH -) (NN match)) (NP (NP (NN F) (HYPH -) (NN measure)) (PP (IN of) (NP (NP (CD 92.2) (NN %)) (CC versus) (NP (CD 91.1) (NN %)) (PRN (-LRB- -LRB-) (NP (NN i2b2) (HYPH -) (CD 2009)) (-RRB- -RRB-)))))) (CC and) (NP (NP (CD 88.4) (NN %)) (CC versus) (NP (CD 81.9) (NN %))))) (PRN (-LRB- -LRB-) (NP (NN APcNER)) (-RRB- -RRB-))) (. .))
(S (PP (IN On) (NP (NN APcNER) (NN corpus))) (, ,) (NP (NP (DT the) (NN micro-average) (NN F) (HYPH -) (NN measure)) (PP (IN of) (NP (NP (DT the) (NN hybrid) (NN system)) (PP (IN on) (NP (DT the) (CD 5) (NNS entities)))))) (VP (VBD was) (NP (NP (NP (CD 69.5) (NN %)) (PP (IN in) (NP (JJ exact) (NN match)))) (, ,) (CC and) (NP (NP (CD 84.1) (NN %)) (PP (IN in) (NP (JJ non-exact) (NN match)))))) (. .))
(S (NP (NNP APcNER)) (VP (VBZ is) (NP (NP (DT a) (JJ French) (NN corpus)) (PP (IN for) (NP (NP (JJ clinical) (HYPH -) (NN NER)) (PP (IN of) (NP (NP (CD five) (NN type)) (PP (IN of) (NP (NP (NNS entities)) (SBAR (WHNP (WDT which)) (S (VP (VBZ covers) (NP (NP (DT a) (JJ large) (NN variety)) (PP (IN of) (NP (NN document) (NNS types))))))))))))))) (. .))
(S (S (VP (VBG Extending) (NP (JJ supervised) (NN model)) (PP (IN with) (NP (NP (NN terminology)) (VP (VBN allowed) (PP (PP (IN for) (NP (DT an) (JJ easy) (NN performance) (NN gain))) (, ,) (RB especially) (PP (IN in) (NP (NP (JJ low) (NNS regimes)) (PP (IN of) (NP (NNS entities))))))))))) (, ,) (CC and) (S (VP (VBN established) (PP (IN near) (NP (NP (NN state)) (PP (IN of) (NP (DT the) (NN art) (NNS results))))) (PP (IN on) (NP (NP (DT the) (NN i2b2)) (HYPH -) (NP (CD 2009) (NN corpus)))))) (. .))
